They called your treatment “experimental.” Your specialist recommended it.
Your insurer calls this “Experimental or investigational”. This page is about what that actually means and what you can do about it.
That label came from a policy document with a review date on it. Medicine moves faster than those documents do — often by years.
Is this your denial? Look for these words on your letter
“experimental”“investigational”“unproven”“not established as effective”
Not sure? Work out which denial you have →
The first thing to do. Ask for their policy on this treatment and look for when it was last reviewed. An out-of-date policy against newer evidence is the whole appeal.
You are not a rare case
40,970
claims denied for this reason in the federal data — 0.1% of all categorised denials. This happens constantly, and it is beaten constantly.
Reason to keep going. This is the category where independent reviewers most often disagree with insurers, because they judge against current published evidence rather than the insurer's internal policy.
What to do about this denial
- Get the exact wording. Ask for the specific plan provision and clinical criteria relied on. The plan must supply it free of charge on request.
- Answer the reason given, not the diagnosis. An appeal that argues the wrong point fails even when the claim is good.
- Get your treating clinician to write the counter. For this denial type especially: a letter of medical necessity citing your records and current clinical guidance is the single most effective document you can add.
- Internal appeal first, then external review. Internal generally within 180 days of the denial; external generally within 4 months of the final internal denial.
Why external review matters here: this denial type turns on medical judgement, which is exactly what external review exists for. Your case is judged by an independent organization that does not work for your insurer, and the insurer is required by law to accept the decision. Nationally, 44% of external reviews went in the patient's favour — yet only 1 in 24,654 denials ever gets there.
Insurers recording the most "experimental or investigational" denials
| Insurer | State | Claims |
|---|---|---|
| Blue Cross Blue Shield of Wyoming | Wyoming | 4,535 |
| Blue Cross and Blue Shield of South Carolina | South Carolina | 4,123 |
| SelectHealth, Inc. | Utah | 3,740 |
| Blue Cross Blue Shield of Illinois | Illinois | 3,372 |
| Wellmark Health Plan of Iowa, Inc. | Iowa | 2,987 |
| Cigna Health and Life Insurance Company | Tennessee | 1,824 |
| Molina Healthcare of Texas, Inc. | Texas | 1,512 |
| Blue Cross and Blue Shield of Kansas, Inc. | Kansas | 1,415 |
| Blue Cross Blue Shield of Michigan Mutual Insurance Company | Michigan | 1,287 |
| HMO Louisiana, Inc. | Louisiana | 1,245 |
| BlueCross BlueShield of Tennessee | Tennessee | 1,188 |
| Blue Cross and Blue Shield of Arizona, Inc. | Arizona | 1,041 |
Everything you need for a "experimental or investigational" denial: your two deadlines, the argument that fits your denial reason, an evidence checklist, and the external review request. Opens on screen the moment you pay.
This page presents federal statistics and a general description of appeal rights created by federal law. It is not legal, medical, or insurance advice, and no outcome is guaranteed. Your denial letter and plan documents govern your specific case. Free help is available from your state's Consumer Assistance Program and from the federal Marketplace at HealthCare.gov.